BioHealth News Archive
IBM Plans to Teach Watson How to Sift Through Medical Images and Diagnose Diseases – MIT Technology Review
IBM says that Watson, its artificial-intelligence technology, can use advanced computer vision to process huge volumes of medical images. Now Watson has its sights…
Read More
Nominations Open: Be the Buzz of BIO at the BIO Investor Forum
Announcing the Buzz of BIO: Recognizing the most innovative companies at the 2015 BIO Investor Forum™ Are you an early-stage company looking for your…
Read More
NIH analysis shows Americans are in pain – ScienceBlog.com
A new analysis of data from the 2012 National Health Interview Survey (NHIS) has found that most American adults have experienced some level of…
Read More
Gliknik Licensee Pfizer Receives Orphan Drug Designation From U.S. Food and Drug Administration For Drug Candidate Directed Towards Rare Neurological Disorder
Gliknik Inc., a privately held biopharmaceutical company, today announced that its licensee Pfizer Inc. (NYSE: PFE) has received notification from the U.S. Food and…
Read More
Could 3D Printers Manufacture the Drugs of the Future?
You can now use 3D printing to create items using a wide range of filaments, and not just plastics. Metals, edibles, bio and construction…
Read More
Epigenomics AG: Epigenomics and BioChain Announce the Inclusion of their Proprietary Blood-based Septin9 Test in the Chinese Screening Guideline for Colorectal Cancer
Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, and BioChain, an early cancer diagnostic company with operations in…
Read More
MedImmune licenses cervical, head and neck cancer vaccine from Inovio Pharmaceuticals – Washington Business Journal
Gaithersburg-based biotech MedImmune entered an exclusive license agreement to work on vaccines targeting cancers caused by human papillomavirus, or HPV. Under the agreement, announced…
Read More
Vasoptic Medical gets $250K investment from Abell Foundation – Technical.ly Baltimore
Bye bye, ‘burbs. Vasoptic Medical is officially a city company now. The medical device startup, which is making a device that allows primary-care doctors to…
Read More
Mobile health called ‘powerful equalizer’ for health disparitiesMedCity News
Mobile health tools will be “a powerful equalizer” in terms of geographic health disparities, according to executives from the Aetna Foundation. Aetna Foundation leaders…
Read More
EDA Announces $10M for Innovation Capacity-Building Activities; SSTI to Host Free Webinar on 2015 RIS Competition – SSTI
Secretary of Commerce Penny Pritzker announced the launch of the Economic Development Administration's (EDA) 2015 Regional Innovation Strategies (RIS) Program competition to spur innovation…
Read More
Inviting Comments and Suggestions on the NIH-wide Strategic Plan
In response to a request from the Congress, NIH is developing a 5-year NIH-wide Strategic Plan to advance its mission to support research in…
Read More
Symbiomix Therapeutics’ First Pivotal Trial Results for SYM-1219 for Bacterial Vaginosis Presented at IDSOG – FirstWord Pharma
Positive results of Symbiomix Therapeutics' first pivotal trial for lead drug candidate SYM-1219, a single-dose, oral product candidate for the treatment of bacterial vaginosis…
Read More
Women In Bio : Washington DC/Baltimore
Originally the national headquarters for WIB, the "Washington DC/Baltimore" chapter officially became its own chapter in October 2011. Located along the I-270 Corridor in Maryland and…
Read More
MedImmune, Mirati to conduct Phase I/II immuno-oncology combination trial to treat lung cancer – Pharmaceutical Business Review
MedImmune, a global biologics R&D arm of AstraZeneca, has entered into an exclusive clinical trial collaboration with Mirati Therapeutics, US-based oncology firm focusing on…
Read More
Emergent BioSolutions Announces Plan to Implement Tax-Free Spin-Off of Biosciences Business Into a Separate Publicly-Traded Company NYSE:EBS
Emergent BioSolutions Inc. (NYSE:EBS) today announced that its Board of Directors has authorized management to pursue a tax-free spin-off of the company's Biosciences business…
Read More